The Taiwan Association for the Study of the Liver yesterday said that there are an estimated 1 million hepatitis B surface antigen (HBsAg) carriers who need medical treatment to prevent the progression of cirrhosis or liver cancer, but only about 170,000 people have accepted treatment.
Taiwan has a relatively high HBsAg-carrier rate of about 10 to 15 percent, said Chien Rong-nan (簡榮南), head of the association and deputy superintendent at Keelung Chang Gung Medical Hospital, adding that the disease is especially prevalent among people above 30 years of age, as hepatitis B vaccinations for newborns were launched in 1984.
“There are an estimated 2.6 to 3 million HBsAg carriers in Taiwan, among them about 1 million to 1.2 million, about 40 percent, are at higher risk of chronic infection and progressing of liver fibrosis, cirrhosis and cancer, so they are in need of medical treatment,” Chien said, adding: “However, medical records from the past 12 years show that only about 170,000 people have sought medical treatment.”
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that attacks the liver, triggering the body’s immune system to target the virus along with infected liver cells, or hepatocytes, thus causing inflammation in the liver, said Dai Chia-yen (戴嘉言), a physician at Kaohsiung Medical University Chung-ho Memorial Hospital.
Liver fibrosis occurs as a result of the repeated injury and repair of hepatocytes, and advanced liver fibrosis can lead to cirrhosis, liver failure or cancer, he said.
“However, because the liver does not contain nerve fibers that sense pain, it is often too late when people notice symptoms associated with liver disease, such as fatigue or nausea,” Dai said.
Statistics obtained through chronic HBV infection screening conducted by Taiwan Liver Research Foundation and the hospital showed that among people found to be hepatitis B carriers, only 43 percent were aware that they were carriers, he said, adding that having a liver examination via a blood test is the best way to prevent and treat the disease at an early stage.
Chien said that a study conducted between 2000 and 2011 on 14,395 chronic hepatitis patients showed that receiving continuous treatment can reduce the prevalence of chronic liver disease and cirrhosis by 22 percent, liver cancer by 14 percent and death from liver cancer by 24 percent.
“Oral medication needs to be taken daily for three years and can effectively suppress the virus, but the disease has a reoccurance rate of 20 to 50 percent after treatment ends,” Chien said, adding that weekly interferon injections for a year is another choice of treatment that can effectively terminate the virus, but might have side effects ,with symptoms similar to a cold.
Patients can discuss with doctors to find out which treatment is best for them, he said, adding that the most important thing is to have regular liver examinations, as well as follow-up examinations or treatment if they are HBsAg carriers.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
The Ministry of Finance this afternoon announced the winning numbers for the March-April uniform invoice lottery. The winning number for the NT$10 million (US$318,060) special prize is 19531471, and the winning number for the NT$2 million grand prize is 85941329. Three numbers were drawn for the NT$200,000 first prize: 07225810, 20231230 and 83518781. Those with receipts matching the last seven digits of any of the first-prize numbers will win the NT$40,000 second prize, while those matching the last six digits will win the NT$10,000 third prize. Those whose receipts match the last five digits of the first-prize numbers can claim the NT$4,000 fourth prize,
Taiwan Travelogue (臺灣漫遊錄), which earlier this week became the first Taiwanese novel to win the International Booker Prize, is to be adapted into a television series through a Taiwan-Japan coproduction, producer Chang Chen-yu (張辰漁) said yesterday. Chang, a producer at World Softest Production Film Co, wrote on Facebook that the company had been searching for projects with international appeal that retain a strong Taiwanese identity after colleagues and Japanese partners strongly recommended the novel. After reading the book, Chang said he immediately decided to pursue the screen rights. “A great story has the power to transcend time and borders, and connect countless people,”
RSS